rs558018

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016156.6(MTMR2):​c.1634A>G​(p.Asn545Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,612,936 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 40 hom. )

Consequence

MTMR2
NM_016156.6 missense

Scores

1
8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.95
Variant links:
Genes affected
MTMR2 (HGNC:7450): (myotubularin related protein 2) This gene is a member of the myotubularin family of phosphoinositide lipid phosphatases. The encoded protein possesses phosphatase activity towards phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4B, an autosomal recessive demyelinating neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0088483095).
BP6
Variant 11-95836284-T-C is Benign according to our data. Variant chr11-95836284-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 194416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-95836284-T-C is described in Lovd as [Benign]. Variant chr11-95836284-T-C is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.012 (1824/152082) while in subpopulation AFR AF= 0.0425 (1763/41518). AF 95% confidence interval is 0.0408. There are 35 homozygotes in gnomad4. There are 866 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 35 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTMR2NM_016156.6 linkc.1634A>G p.Asn545Ser missense_variant Exon 14 of 15 ENST00000346299.10 NP_057240.3 Q13614-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTMR2ENST00000346299.10 linkc.1634A>G p.Asn545Ser missense_variant Exon 14 of 15 1 NM_016156.6 ENSP00000345752.6 Q13614-1

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1820
AN:
151964
Hom.:
35
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0425
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.00431
GnomAD3 exomes
AF:
0.00293
AC:
734
AN:
250808
Hom.:
12
AF XY:
0.00199
AC XY:
269
AN XY:
135516
show subpopulations
Gnomad AFR exome
AF:
0.0411
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000442
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00124
AC:
1805
AN:
1460854
Hom.:
40
Cov.:
32
AF XY:
0.00108
AC XY:
782
AN XY:
726724
show subpopulations
Gnomad4 AFR exome
AF:
0.0454
Gnomad4 AMR exome
AF:
0.00184
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000279
Gnomad4 OTH exome
AF:
0.00244
GnomAD4 genome
AF:
0.0120
AC:
1824
AN:
152082
Hom.:
35
Cov.:
32
AF XY:
0.0116
AC XY:
866
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.0425
Gnomad4 AMR
AF:
0.00282
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000133
Gnomad4 OTH
AF:
0.00427
Alfa
AF:
0.00219
Hom.:
7
Bravo
AF:
0.0135
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0388
AC:
171
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00344
AC:
417
Asia WGS
AF:
0.00289
AC:
11
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

MTMR2: BS1, BS2 -

Oct 29, 2018
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:2
Apr 02, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 02, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Charcot-Marie-Tooth disease type 4B1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Charcot-Marie-Tooth disease type 4 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.75
D;.;.;.;T
Eigen
Benign
0.19
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.96
D;D;.;.;D
MetaRNN
Benign
0.0088
T;T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Uncertain
2.7
M;.;.;.;.
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-4.5
D;D;D;D;D
REVEL
Uncertain
0.45
Sift
Benign
0.037
D;D;D;D;D
Sift4G
Benign
0.096
T;T;T;T;.
Polyphen
0.38
B;.;.;.;.
Vest4
0.78
MVP
0.89
MPC
0.34
ClinPred
0.12
T
GERP RS
5.8
Varity_R
0.28
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs558018; hg19: chr11-95569448; API